APA (7th ed.) Citation

S, S., Z, L., & EY, S. (2017). Phosphatidlyinositol-3-kinase C2 beta (PI3KC2β) is a potential new target to treat IgE mediated disease. PloS one, 12(8), e0183474. https://doi.org/10.1371/journal.pone.0183474

Chicago Style (17th ed.) Citation

S, Srivastava, Li Z, and Skolnik EY. "Phosphatidlyinositol-3-kinase C2 Beta (PI3KC2β) Is a Potential New Target to Treat IgE Mediated Disease." PloS One 12, no. 8 (2017): e0183474. https://doi.org/10.1371/journal.pone.0183474.

MLA (9th ed.) Citation

S, Srivastava, et al. "Phosphatidlyinositol-3-kinase C2 Beta (PI3KC2β) Is a Potential New Target to Treat IgE Mediated Disease." PloS One, vol. 12, no. 8, 2017, p. e0183474, https://doi.org/10.1371/journal.pone.0183474.